SCLX$1.8510.19%-0.21
After Hours: 1.89+0.04 +2.16%
Scilex Holding Company (SCLX)
Date: 2026-10-30 16:00O: 2.05H: 2.06L: 1.83C: 1.85Vol: 47.59k
Scilex Holding Company stock is traded at $1.85, with a volume of 47,585. It is down -10.19% in the last 24 hours and down -58.43% over the past month. Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Previous Close:
$2.06
Open:
$2.05
24h Volume:
47,585
Relative Volume:
1.19
Market Cap:
$13.01M
Revenue:
$33.86M
Net Income/Loss:
-$437.38M
P/E Ratio:
-
EPS:
-$40.58
Net Cash Flow:
-$42.07M
1W Performance:
-21.28%
1M Performance:
-58.43%
6M Performance:
-82.41%
1Y Performance:
-89.75%
1-Day Range:
$1.83$2.06
1-Week Range:
$1.83$2.40
52-Week Range:
$1.83$27.00
Scilex Holding Company Stock (SCLX) Company Profile
Name
Scilex Holding CompanySector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(650) 516-4310Address
960 SAN ANTONIO ROAD, PALO ALTO, USACompare SCLX vs LLY, JNJ, ABBV, MRK, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCLX Scilex Holding Company | $1.85 | $13.01M | $33.86M | -$437.38M | -$42.07M | -$40.58 |
 LLY Lilly Eli Co | $1,417.54 | $1.26T | $72.25B | $25.28B | $10.37B | $27.78 |
 JNJ Johnson Johnson | $273.20 | $657.68B | $97.93B | $21.04B | $17.80B | $8.63 |
 ABBV Abbvie Inc | $294.89 | $521.11B | $62.82B | $3.60B | $19.98B | $2.03 |
 MRK Merck Co Inc | $149.52 | $368.89B | $65.51B | $8.93B | $14.12B | $3.55 |
 NVS Novartis Ag Adr | $160.79 | $303.67B | $54.66B | $13.58B | $16.05B | $7.02 |
Scilex Holding Company Stock (SCLX) Upgrades & Downgrades
Scilex Holding Company Stock (SCLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Scilex Holding Company Stock (SCLX) Insider Trading
- Scilex Holding CoDec 30 '2510% Owner
- Transaction
- Sale
- Cost
- $0.54
- #Shares
- 9,657,300
- Value ($)
- 5,209,148
- #Shares Total
- 244,445,260
- Scilex Holding CoDec 29 '2510% Owner
- Transaction
- Sale
- Cost
- $0.66
- #Shares
- 7,310,984
- Value ($)
- 4,792,350
- #Shares Total
- 254,102,560
- Scilex Holding CoDec 26 '2510% Owner
- Transaction
- Sale
- Cost
- $0.75
- #Shares
- 3,689,016
- Value ($)
- 2,770,082
- #Shares Total
- 261,413,544
- 10% Owner
- Transaction
- Sale
- Cost
- $16.00
- #Shares
- 11,945,151
- Value ($)
- 191,122,416
- #Shares Total
- 181,804,849
- 10% Owner
- Transaction
- Sale
- Cost
- $16.00
- #Shares
- 554,849
- Value ($)
- 8,877,584
- #Shares Total
- 500,000
